BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3490498)

  • 1. Clinical and acoustical variability in hypokinetic dysarthria.
    Metter EJ; Hanson WR
    J Commun Disord; 1986 Oct; 19(5):347-66. PubMed ID: 3490498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing intonation deficit in motor speech disorders: an autosegmental-metrical analysis of spontaneous speech in hypokinetic dysarthria, ataxic dysarthria, and foreign accent syndrome.
    Lowit A; Kuschmann A
    J Speech Lang Hear Res; 2012 Oct; 55(5):1472-84. PubMed ID: 23033442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptual analysis of speech disorders in progressive supranuclear palsy.
    Kluin KJ; Foster NL; Berent S; Gilman S
    Neurology; 1993 Mar; 43(3 Pt 1):563-6. PubMed ID: 8451002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markerless Analysis of Articulatory Movements in Patients With Parkinson's Disease.
    Bandini A; Orlandi S; Giovannelli F; Felici A; Cincotta M; Clemente D; Vanni P; Zaccara G; Manfredi C
    J Voice; 2016 Nov; 30(6):766.e1-766.e11. PubMed ID: 26620259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
    Kowalska-Taczanowska R; Friedman A; Koziorowski D
    Brain Behav; 2020 Aug; 10(8):e01700. PubMed ID: 32525283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of motor speech function in the diagnosis of various forms of dysarthria].
    Auzou P; Ozsancak C; Jan M; Ménard JF; Eustache F; Hannequin D
    Rev Neurol (Paris); 2000 Jan; 156(1):47-52. PubMed ID: 10693258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptual characteristics of Cantonese hypokinetic dysarthria.
    Whitehill TL; Ma JK; Lee AS
    Clin Linguist Phon; 2003; 17(4-5):265-71. PubMed ID: 12945601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse.
    Selikhova M; Tripoliti E; Fedoryshyn L; Matvienko Y; Stanetska H; Boychuk M; Komnatska I; Lees AJ; Sanotsky Y
    Clin Neurol Neurosurg; 2016 Aug; 147():71-7. PubMed ID: 27310289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy.
    Clark HM; Utianski RL; Ali F; Botha H; Whitwell JL; Josephs KA
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1361-1372. PubMed ID: 33719524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy.
    Rusz J; Tykalová T; Salerno G; Bancone S; Scarpelli J; Pellecchia MT
    J Neurol; 2019 Jun; 266(6):1394-1404. PubMed ID: 30859316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological correlates of dysarthria in progressive supranuclear palsy.
    Kluin K; Gilman S; Foster N; Sima A; D'Amato C; Bruch L; Bluemlein L; Little R; Johanns J
    Arch Neurol; 2001 Feb; 58(2):265-9. PubMed ID: 11176965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electromyographic study of 4 lip muscles and acoustic findings in parkinsonian dysarthria].
    Pellat J; Gentil M; Chevalier C; Vila A; Pollak P; Perret J
    Rev Neurol (Paris); 1983; 139(3):205-13. PubMed ID: 6612135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spastic dysarthria after acquired brain injury: an acoustic study.
    Ziegler W; von Cramon D
    Br J Disord Commun; 1986 Aug; 21(2):173-87. PubMed ID: 3828204
    [No Abstract]   [Full Text] [Related]  

  • 16. Images in neuroscience. Progressive dysarthria: structural and brain correlations.
    Selnes OA; Holcomb HH; Gordon B
    Am J Psychiatry; 1996 Mar; 153(3):309-10. PubMed ID: 8610816
    [No Abstract]   [Full Text] [Related]  

  • 17. Vocal tract steadiness: a measure of phonatory and upper airway motor control during phonation in dysarthria.
    Zwirner P; Barnes GJ
    J Speech Hear Res; 1992 Aug; 35(4):761-8. PubMed ID: 1405531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech disorders in olivopontocerebellar atrophy correlate with positron emission tomography findings.
    Kluin KJ; Gilman S; Markel DS; Koeppe RA; Rosenthal G; Junck L
    Ann Neurol; 1988 Jun; 23(6):547-54. PubMed ID: 3261572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Speech disorders in extrapyramidal diseases].
    Budrewicz S; Słotwiński K; Podemski R
    Neurol Neurochir Pol; 2003; 37 Suppl 5():47-54. PubMed ID: 15098331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of interutterance stability: application to dysarthria.
    Cummins F; Lowit A; van Brenk F
    J Speech Lang Hear Res; 2014 Feb; 57(1):81-9. PubMed ID: 24687469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.